Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancer.
Chaubal R, Talker E, Chitra J, Kadam R, Gardi N, Ursekar R, Kadam A, Singh A, Sale S, Pandey S, Madhav M, Raja A, Mukhare R, Parab P, Shetty N, Gala K, Kulkarni S, Gandhi KA, Gulia S, Joshi S, Shet T, Gupta S.
Chaubal R, et al. Among authors: singh a.
Breast Cancer Res Treat. 2025 Jul 12. doi: 10.1007/s10549-025-07759-7. Online ahead of print.
Breast Cancer Res Treat. 2025.
PMID: 40652157